Updated advice on use of nicorandil as second-line treatment for stable angina – some ulcers may progress to complications unless treatment is stopped. More information here
Read more →
by Kazeem Olalekan MRPharmS The Medicines and Healthcare products Regulatory Agency has just issued a Class 4 Drug Safety Alert for Wockhardt UK Ltd – Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection. Alert details Drug alert number EL (14)A/09 in connection with the
Read more →
by Kazeem Olalekan Over the last month, a number of important alerts have been posted on the MHRA website which we, at bookapharmacist.com, will like to draw attention (NOTE: We continue to Tweet MHRA alerts on our Twitter page – @bookapharmacist under the hashtag #mhra – so be
Read more →
by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately
Read more →
A class 4 alert has been issued for Priadel Liquid by the MHRA. Priadel Liquid (Lithium Citrate 520mg/5ml equivalent to Lithium Carbonate 204mg/5ml) appears cloudy rather than clear. A detailed investigation carried out by Sanofi, the manufacturer, “has shown that the cloudiness is not due to microbial
Read more →
A class 1 drug alert (FOR IMMEDIATE ACTION) was posted on the MHRA website last week for Co-codamol 8/500 (codeine phosphate 8mg, paracetamol 500mg) containing rogue Co-codamol 30/500 tablets! The brand affected was manufactured by Wockhardt UK Ltd. Batch No: LL11701. Excerpts from the MHRA website
Read more →
Action within 5 days Genus Pharmaceuticals Ltd is temporarily ceasing manufacture of the above product and recalling all remaining stock from pharmacy and wholesaler level. This is due to a small number of problems during implantation and the product is being withdrawn until the implantation system can
Read more →
Gaviscon Advance Peppermint Flavour Oral suspension containing sodium alginate 500mg and potassium bicarbonate 100mg in 5ml PL 0063/0103 Batch Number Expiry Date Pack Size First Distributed 924471 1/08/2011 500 ml bottle 19/09/2009 925071 1/09/2011 500 ml bottle 19/09/2009 Reckitt Benckiser Healthcare (UK) Ltd are recalling the above
Read more →
MHRA has just posted this Drug Safety Information with respect to Phenergan Elixir PL 04425/0630, 100ml packs. The labelling may “cause confusion to diabetic patients”. This relates to the technical distinction between hydrogenated glucose (which is not considered as sugar and therefore does not carry the risks
Read more →
The images above illustrate an important point about parallel import of medication. At first glance the Oxis Turbohaler on the left shows a strength of 9 microgram and on the other side of the same Turbohaler, the English label shows 12 microgram (picture on the right). It
Read more →We have just receive some indication from the manufacturers (Sanofi Aventis + Bristol-Myer Squibb ) that Clopidogrel-containing medicines and proton pump inhibitors (PPIs) ‘should be avoided unless absolutely necessary’. The preliminary studies indicate a cytochrome P450-type interaction. Clopidogrel is a pro-drug which is metabolised in the liver,
Read more →
The MHRA has just posted another Class 4 Alert relating to the patient information leaflet (PIL) of Timoptol-LA 0.25% w/v & 0.5% w/v Gel-Forming Eye Drops Solutions. The dose printed on the PIL is wrong. It states a dose of twice a day instead of the correct
Read more →
We have just been alerted to this packaging issue with Priadel 400mg Prolonged Release. The labelling on the rear panel of the cartons are wrong. On the side of the box where you place the dispensing label, you have Lithium Carbonate 200mg incorrectly printed on it. Please
Read more →